TABLE 5.
Clinical Characteristics and Treatment in Cancer Patients Enrolled in RIETE and Treated by Anticoagulation for VTE With Fatal Recurrent PE or Fatal Bleeding According to Time of Presentation
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.